Cargando…
Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems
BACKGROUND: This study aimed to explore the opinions of healthcare professionals regarding the management of men with advanced prostate cancer with particular emphasis on treatment timing and sequencing; treatment adverse-effects and exercise a supportive therapy. METHODS: Semi-structured interviews...
Autores principales: | Greasley, Rosa U., Turner, Rebecca, Collins, Karen, Brown, Janet, Bourke, Liam, Rosario, Derek J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006691/ https://www.ncbi.nlm.nih.gov/pubmed/29914436 http://dx.doi.org/10.1186/s12885-018-4527-y |
Ejemplares similares
-
A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer
por: Greasley, Rosa, et al.
Publicado: (2015) -
STAMPEDEing metastatic prostate cancer: CHAARTing the LATITUDEs
por: Sharma, Aditya Prakash, et al.
Publicado: (2018) -
Treatment of metastatic prostate cancer after STAMPEDE
por: Wolf, Philipp
Publicado: (2017) -
A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHS
por: Bourke, Liam, et al.
Publicado: (2018) -
Hypertension in malignancy–an underappreciated problem
por: Małyszko, Jolanta, et al.
Publicado: (2018)